TY - JOUR
T1 - Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
AU - Parchi, Piero
AU - Giese, Armin
AU - Capellari, Sabina
AU - Brown, Paul
AU - Schulz-Schaeffer, Walter
AU - Windl, Otto
AU - Zerr, Inga
AU - Budka, Herbert
AU - Kopp, Nicolas
AU - Piccardo, Pedro
AU - Poser, Sigrid
AU - Rojiani, Amyn
AU - Streichemberger, Nathalie
AU - Julien, Jean
AU - Vital, Claude
AU - Ghetti, Bernardino
AU - Gambetti, Pierluigi
AU - Kretzschmar, Hans
PY - 1999
Y1 - 1999
N2 - Phenotypic heterogeneity in sporadic Creutzfeldt-Jakob disease (sCJD) is well documented, but there is not yet a systematic classification of the disease variants. In a previous study, we showed that the polymorphic codon 129 of the prion protein gene (PRNP), and two types of protease-resistant prion protein (PrP(Sc)) with distinct physicochemical properties, are major determinants of these variants. To define the full spectrum of variants, we have examined a series of 300 sCJD patients. Clinical features, PRNP genotype, and PrP(Sc) properties were determined in all subjects. In 187, we also studied neuropathological features and immunohistochemical pattern of PrP(Sc) deposition. Seventy percent of subjects showed the classic CJD phenotype, PrP(Sc) type 1, and at least one methionine allele at codon 129; 25% of cases displayed the ataxic and kuru-plaque variants, associated to PrP(Sc) type 2, and valine homozygosity or heterozygosity at codon 129, respectively. Two additional variants, which included a thalamic form of CJD and a phenotype characterized by prominent dementia and cortical pathology, were linked to PrP(Sc) type 2 and methionine homozygosity. Finally, a rare phenotype characterized by progressive dementia was linked to PrP(Sc) type 1 and valine homozygosity. The present data demonstrate the existence of six phenotypic variants of sCJD. The physicochemical properties of PrP(Sc) in conjunction with the PRNP codon 129 genotype largely determine this phenotypic variability, and allow a molecular classification of the disease variants.
AB - Phenotypic heterogeneity in sporadic Creutzfeldt-Jakob disease (sCJD) is well documented, but there is not yet a systematic classification of the disease variants. In a previous study, we showed that the polymorphic codon 129 of the prion protein gene (PRNP), and two types of protease-resistant prion protein (PrP(Sc)) with distinct physicochemical properties, are major determinants of these variants. To define the full spectrum of variants, we have examined a series of 300 sCJD patients. Clinical features, PRNP genotype, and PrP(Sc) properties were determined in all subjects. In 187, we also studied neuropathological features and immunohistochemical pattern of PrP(Sc) deposition. Seventy percent of subjects showed the classic CJD phenotype, PrP(Sc) type 1, and at least one methionine allele at codon 129; 25% of cases displayed the ataxic and kuru-plaque variants, associated to PrP(Sc) type 2, and valine homozygosity or heterozygosity at codon 129, respectively. Two additional variants, which included a thalamic form of CJD and a phenotype characterized by prominent dementia and cortical pathology, were linked to PrP(Sc) type 2 and methionine homozygosity. Finally, a rare phenotype characterized by progressive dementia was linked to PrP(Sc) type 1 and valine homozygosity. The present data demonstrate the existence of six phenotypic variants of sCJD. The physicochemical properties of PrP(Sc) in conjunction with the PRNP codon 129 genotype largely determine this phenotypic variability, and allow a molecular classification of the disease variants.
UR - http://www.scopus.com/inward/record.url?scp=0032816292&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032816292&partnerID=8YFLogxK
U2 - 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W
DO - 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W
M3 - Article
C2 - 10443888
AN - SCOPUS:0032816292
SN - 0364-5134
VL - 46
SP - 224
EP - 233
JO - Annals of Neurology
JF - Annals of Neurology
IS - 2
ER -